Portal de investigação
Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Fernandes, M
- Marques, H
- Teixeira, AL
Abstract
Non-Hodgkin lymphoma (NHL) is characterized by a great variability in patient outcomes, resulting in the critical need for identifying new molecular prognostic biomarkers. This study aimed to identify novel circulating prognostic biomarkers based on an miRNA/lncRNA-associated ceRNA network for NHL. Using bioinformatic analysis, we identified the miRNA-lncRNA pairs, and using RT-qPCR, we analyzed their plasma levels in a cohort of 113 NHL patients to assess their prognostic value. Bioinformatic analysis identified SNHG16 and SNHG6 as hsa-miR-20a-5p and hsa-miR-181a-5p sponges, respectively. Plasma levels of hsa-miR-20a-5p/SNHG16 and hsa-miR-181a-5p/SNG6 were significantly associated with more aggressive disease and IPI/FLIPI scores. Moreover, we found that patients with risk expression profiles of hsa-miR-20a-5p/SNHG16 and hsa-miR-181a-5p/SNHG6 presented a higher risk of positive bone marrow involvement. Moreover, hsa-miR-20a-5p/SNHG16 and hsa-miR-181a-5p/SNHG6 pairs' plasma levels were associated with overall survival and progression-free survival of NHL patients, being independent prognostic factors in a multivariate Cox analysis. The prediction models incorporating the ceRNA network expression analysis improved the predictive capacity compared to the model, which only considered the clinicopathological variables. There are still few studies on using the ceRNA network as a potential prognostic biomarker, particularly in NHL, which may permit the implementation of a more personalized management of these patients.
Dados da publicação
- ISSN/ISSNe:
- 2227-9059, 2227-9059
- Tipo:
- Article
- Páginas:
- 1322-
- Link para outro recurso:
- www.scopus.com
Biomedicines MDPI AG
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 3
Documentos
- Não há documentos
Filiações
Keywords
- non-Hodgkin lymphoma; miRNA; lncRNA; ceRNA network; prognosis; biomarker
Proyectos asociados
Previsão das readmissões dos doentes à Urgência Pediátrica: aplicação das técnicas de aprendizagem supervisionadas.
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Observacional Académico (UrgPediatr) . 2019
Identificação de determinantes farmacogenómicas preditivas de resposta ao tratamento em doentes com cancro do colo do útero
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Clínico Académico . 2021
Pharmacoepigenomic profile of ovarian cancer patients submitted to taxane-based chemoteherapy
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Clínico Académico . 2020
Anal squamous intraepithelial lesions
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Clínico Académico . 2020
Characterization of Pain and Genetic Variants Associated with Pain in Patients with Metastatic Bone Disease
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Clínico Académico . 2019
Citar a publicação
Fernandes M,Marques H,Teixeira AL,Medeiros R. Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study. Biomedicines. 2022. 10. (6):p. 1322-1322. IF:4,700. (1).
